(Q37245872)

19 August 2017

1 reference

title

Collagen vascular diseases of childhood (English)

1 reference

19 August 2017

Jones EM

1

1 reference

19 August 2017

Callen JP

series ordinal

2

1 reference

19 August 2017

publication date

1 August 1991

1 reference

Pediatric Clinics of North America

19 August 2017

published in

1 reference

19 August 2017

volume

38

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

1019-1039

1 reference

The neonatal lupus syndrome, autoantibodies, and connective tissue disease

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Anaphylactoid purpura in children (Schonlein-Henoch syndrome): review with a follow-up of the renal complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Henoch-Schönlein Nephritis: Prognostic Features and the Challenge of Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Dermatomyositis (systemic angiopathy) of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Neonatal lupus erythematosus occurring in one fraternal twin. Serologic and immunogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

The childhood type of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Increased IgA-producing cells in the blood of patients with active Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

1 reference

7 January 2021

Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Scleroderma in the child

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Juvenile dermatomyositis treated with cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Plasmapheresis in childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Disabling pansclerotic morphea of children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Discoid lupus erythematosus in a newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

High titers of antibodies to single-stranded DNA in linear scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Systemic lupus erythematosus within the first two decades of life

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Dermatomyositis-polymyositis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Neonatal lupus erythematosus progressing into systemic lupus erythematosus. A 15 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Neonatal Lupus Erythematosus: New Serologic Findings

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Immunogenetics of the neonatal lupus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

The role of antibodies directed against double-stranded DNA in the manifestations of systemic lupus erythematosus in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Neonatal lupus erythematosus with heart block: family study of a patient with anti-SS-A and SS-B antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Maternal and fetal outcome in neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Drug treatment of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Female predominance of immune response to SSA/Ro antigens and risk of neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Systemic lupus erythematosus: important considerations in the adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

A cutaneous sign of IgA-associated small dermal vessel leukocytoclastic vasculitis in adults (Henoch-Schönlein purpura)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Dermatomyositis in childhood; a summary of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Cutaneous changes of dermatomyositis precede muscle weakness

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Viral studies in benign acute childhood myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Acute hemorrhagic edema of infancy (AHEI)--a variant of Henoch-Schönlein purpura or a distinct clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Antinuclear antibody in Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Course of treated juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Juvenile progressive systemic sclerosis: clinical and serologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

Antinuclear antibodies in localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

1 reference

7 January 2021

Juvenile linear scleroderma associated with serologic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938165-2

7 January 2021

10.1016/S0031-3955(16)38165-2

Identifiers

DOI

0 references

1 reference